Bio

Ingrid Atteryd Heiman, born in 1958, has a bachelor’s degree in finance and industrial marketing from Lund University and a MBA in International Business from Uppsala University. Atteryd Heiman has broad experience in business management and board work from food, pharmaceuticals, biomedicine, life science, women’s health and financial services, as well as international business including business development in Europe, the USA and Asia. Atteryd Heiman’s other assignments include:

Board member of VitalSigns AB, Colzyx AB and CHOSA Oncology.

Previous assignments include, board memeber in: Amniotics AB (publ), CarpoNovum AB, Ilama AB, Pharmiva AB (publ), and Redwood Pharma AB (publ).

Ingrid Atteryd Heiman does not hold any shares in the Company.

Ingrid Atteryd Heiman

Board Chair

Experience

  • Chair of the Board, CHOSA Oncology

  • Chairman & Board Member, Doxa AB

  • CEO & Chairman, Ellen AB

  • CEO & Chairman, Swedish Self-Care Association

  • CEO & Chairman, European Self-Care Industry Association

  • Board Member, Colzyx AB

  • Board Member, VitalSigns AB

Key Achievements

  • 30+ years of executive and board leadership across life science, pharmaceuticals and medical technology

  • Extensive experience in corporate governance, strategy and international business development

  • Advised and supported numerous listed and private life science companies through financing and growth

  • Strong background in capital markets, investor relations and strategic communications

  • Broad international leadership experience across Europe, the United States and Asia